6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells
Open Access
- 1 January 2017
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 25 (1) , 79-91
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Institutes of Health (P30CA033572)
This publication has 63 references indexed in Scilit:
- Identification of siRNA delivery enhancers by a chemical library screenNucleic Acids Research, 2015
- The anti-miR21 antagomir, a therapeutic tool for colorectal cancer, has a potential synergistic effect by perturbing an angiogenesis-associated miR30Frontiers in Genetics, 2014
- Indirubin Derivative 6BIO Suppresses MetastasisCancer Research, 2013
- GSK3 Inhibitor-BIO Regulates Proliferation of Immortalized Pancreatic Mesenchymal Stem Cells (iPMSCs)PLOS ONE, 2012
- Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfectionGene Therapy, 2010
- Glycogen Synthase Kinase-3β Is Involved in the Phosphorylation and Suppression of Androgen Receptor ActivityJournal of Biological Chemistry, 2004
- Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent KinasesJournal of Medicinal Chemistry, 2004
- GSK-3-Selective Inhibitors Derived from Tyrian Purple IndirubinsChemistry & Biology, 2003
- GSK-3: tricks of the trade for a multi-tasking kinaseJournal of Cell Science, 2003
- Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinasesNature Cell Biology, 1999